From the Departments of Epidemiology (Y.M., Q.S., G.C.C., M.W., E.B.R., J.E.M., W.C.W., A.H., N.R.C., F.B.H.) and Nutrition (Q.S., C.Y., E.B.R., W.C.W., F.B.H.), Harvard T.H. Chan School of Public Health, and the Channing Division of Network Medicine, the Department of Medicine (Q.S., G.C.C., E.B.R., J.E.M., W.C.W., F.B.H.), Renal Division, the Department of Medicine (G.C.C.), and the Division of Preventive Medicine (J.E.M., N.R.C.), Brigham and Women's Hospital and Harvard Medical School - all in Boston; the Wolfson Institute of Population Health, St. Bartholomew's Hospital and the London School of Medicine and Dentistry, Queen Mary University of London, London (F.J.H., G.A.M.); the Department of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (L.M.K., S.J.L.B., R.T.G.); and the Departments of Medicine, Community Health Sciences, and Physiology and Pharmacology, O'Brien Institute of Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada (N.R.C.C.).
N Engl J Med. 2022 Jan 20;386(3):252-263. doi: 10.1056/NEJMoa2109794. Epub 2021 Nov 13.
The relation between sodium intake and cardiovascular disease remains controversial, owing in part to inaccurate assessment of sodium intake. Assessing 24-hour urinary excretion over a period of multiple days is considered to be an accurate method.
We included individual-participant data from six prospective cohorts of generally healthy adults; sodium and potassium excretion was assessed with the use of at least two 24-hour urine samples per participant. The primary outcome was a cardiovascular event (coronary revascularization or fatal or nonfatal myocardial infarction or stroke). We analyzed each cohort using consistent methods and combined the results using a random-effects meta-analysis.
Among 10,709 participants, who had a mean (±SD) age of 51.5±12.6 years and of whom 54.2% were women, 571 cardiovascular events were ascertained during a median study follow-up of 8.8 years (incidence rate, 5.9 per 1000 person-years). The median 24-hour urinary sodium excretion was 3270 mg (10th to 90th percentile, 2099 to 4899). Higher sodium excretion, lower potassium excretion, and a higher sodium-to-potassium ratio were all associated with a higher cardiovascular risk in analyses that were controlled for confounding factors (P≤0.005 for all comparisons). In analyses that compared quartile 4 of the urinary biomarker (highest) with quartile 1 (lowest), the hazard ratios were 1.60 (95% confidence interval [CI], 1.19 to 2.14) for sodium excretion, 0.69 (95% CI, 0.51 to 0.91) for potassium excretion, and 1.62 (95% CI, 1.25 to 2.10) for the sodium-to-potassium ratio. Each daily increment of 1000 mg in sodium excretion was associated with an 18% increase in cardiovascular risk (hazard ratio, 1.18; 95% CI, 1.08 to 1.29), and each daily increment of 1000 mg in potassium excretion was associated with an 18% decrease in risk (hazard ratio, 0.82; 95% CI, 0.72 to 0.94).
Higher sodium and lower potassium intakes, as measured in multiple 24-hour urine samples, were associated in a dose-response manner with a higher cardiovascular risk. These findings may support reducing sodium intake and increasing potassium intake from current levels. (Funded by the American Heart Association and the National Institutes of Health.).
钠摄入量与心血管疾病之间的关系仍存在争议,部分原因是钠摄入量的评估不准确。评估多天内的 24 小时尿液排泄量被认为是一种准确的方法。
我们纳入了来自六个一般健康成年人的前瞻性队列的个体参与者数据;每个参与者至少使用两个 24 小时尿液样本来评估钠和钾的排泄量。主要结局是心血管事件(冠状动脉血运重建或致命或非致命性心肌梗死或中风)。我们使用一致的方法分析每个队列,并使用随机效应荟萃分析综合结果。
在 10709 名参与者中,平均(±SD)年龄为 51.5±12.6 岁,其中 54.2%为女性,中位研究随访 8.8 年期间确定了 571 例心血管事件(发生率为每 1000 人年 5.9 例)。24 小时尿液钠排泄中位数为 3270mg(第 10 至 90 个百分位数,2099 至 4899)。在控制混杂因素的分析中,较高的钠排泄量、较低的钾排泄量和较高的钠/钾比值均与较高的心血管风险相关(所有比较的 P≤0.005)。在将尿液生物标志物的第 4 四分位数(最高)与第 1 四分位数(最低)进行比较的分析中,钠排泄的危险比为 1.60(95%置信区间 [CI],1.19 至 2.14),钾排泄的危险比为 0.69(95% CI,0.51 至 0.91),钠/钾比值的危险比为 1.62(95% CI,1.25 至 2.10)。每天增加 1000mg 的钠排泄与心血管风险增加 18%相关(危险比,1.18;95% CI,1.08 至 1.29),每天增加 1000mg 的钾排泄与风险降低 18%相关(危险比,0.82;95% CI,0.72 至 0.94)。
在多次 24 小时尿液样本中测量的钠摄入量较高和钾摄入量较低与心血管风险呈剂量反应关系。这些发现可能支持从目前水平减少钠摄入和增加钾摄入。(由美国心脏协会和美国国立卫生研究院资助)。